AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 772827
Drug: Penicillin 50,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penicillin 50,000 U/kg/d and Kanamycin 10 mg/kg/d
Trial: 26332338
Drug: Wii-based Movement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wii-based Movement Therapy
Trial: 26332338
Drug: modified Constraint-induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: modified Constraint-induced Movement Therapy
Trial: 23645374
Drug: PureVision SH
RxNorm normalized name: Glutathione-SH
DrugBank: Glutathione (DB00143)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PureVision SH lenses with Alcon Opti‐Free Express solution
Trial: 23645374
Drug: PureVision SH
RxNorm normalized name: Glutathione-SH
DrugBank: Glutathione (DB00143)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PureVision SH lenses with Renu Fresh solution
Trial: 21590284
Drug: Methylphenidate (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (10, 20, and 40 mg)
Trial: 8444070
Drug: Metronidazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (400 mg twice a day)
Trial: 8444070
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no drug regimen)
Trial: 17578359
Drug: Monsel's solution
RxNorm normalized name: Monsel's solution
DrugBank: Ferric subsulfate (DB13885)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monsel's solution
Trial: 21174751
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment combined with hyperbaric oxygen therapy (HBOT) for two weeks
Trial: 21174751
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment alone for two weeks
Trial: 21174751
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment combined with HBOT
Trial: 19012813
Drug: Triple-bead mixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-bead mixed amphetamine salts (starting dose 12.5 mg)
Trial: 15869337
Drug: Empirically supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirically supported treatments
Trial: 10635188
Drug: Implant supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implant supported FPDs (two implants)
Trial: 10635188
Drug: Tooth-implant supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tooth-implant supported FPDs (one implant and one tooth)
Trial: 1758244
Drug: Clonidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (1 ml, 0.15 mg) with 3 ml 0.5% hyperbaric bupivacaine
Trial: 1758244
Drug: Saline (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (3 ml 0.5% hyperbaric bupivacaine plus 1 ml normal saline)
Trial: 25661270
Drug: Acupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture plus conventional analgesic treatment
Trial: 25661270
Drug: Conventional postoperative
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional postoperative analgesic treatment
Trial: 23399382
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch (14 mg for smokers, 7 mg for non-smokers)
Trial: 8610716
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (500 micrograms) + albuterol (2.5 mg)
Trial: 8610716
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + albuterol (2.5 mg)
Trial: 1826567
Drug: Low-dose intradermal
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intradermal recombinant-derived hepatitis B vaccine (1.0 or 1.5 microgram)
Trial: 1826567
Drug: Standard intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intramuscular dose of hepatitis B vaccine
Trial: 7080491
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg bemetizide, 20 mg triamterene, 20 mg dihydralazine and 20 mg bupranolol (multiple dose regimen)
Trial: 7080491
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg bemetizide, 20 mg triamterene, 20 mg dihydralazine and 20 mg bupranolol (single dose regimen)
Trial: 28120351
Drug: Topical tacrolimus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tacrolimus applied twice daily for 3 weeks
Trial: 28120351
Drug: Topical clotrimazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical clotrimazole applied twice daily for 3 weeks
Trial: 21804410
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment with open reduction and internal fixation using an angular stable plate and cerclages, with physical therapy starting on the third postoperative day.
Trial: 21804410
Drug: Conservative closed
RxNorm normalized name: Conserved dopamine neurotrophic factor
DrugBank: HER-902 (DB17948)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative closed treatment including closed reduction if displacement exceeded 50% of the diaphyseal diameter, with physical therapy starting on the fifteenth postoperative day.
Trial: 9650546
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) 650 mg with codeine 60 mg
Trial: 2711990
Drug: Nicardipine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 10 mg administered 3 times daily
Trial: 2711990
Drug: Nicardipine 20
RxNorm normalized name: nicardipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 20 mg administered 3 times daily
Trial: 2711990
Drug: Nicardipine 30
RxNorm normalized name: niCARdipine 30 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 30 mg administered 3 times daily
Trial: 2751476
Drug: Probucol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probucol (500 mg twice daily)
Trial: 31474339
Drug: Detomidine gel
RxNorm normalized name: detomidine Oral Gel
DrugBank: Detomidine (DB11556)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Detomidine gel (40 μg kg‐1) intravaginally (treatment IVG)
Trial: 31474339
Drug: Detomidine hydrochloride
RxNorm normalized name: Detomidine Hydrochloride
DrugBank: Detomidine (DB11556)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Detomidine hydrochloride (10 μg kg‐1) intravenously (treatment IV)
Trial: 28462683
Drug: Carotid endarterectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotid endarterectomy plus intensive medical therapy
Trial: 28462683
Drug: Carotid stenting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotid stenting plus intensive medical therapy
Trial: 21872138
Drug: Nebivolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol (10 mg/d)
Trial: 15184276
Drug: Carvedilol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (50 mg/d)
Trial: 7637536
Drug: Glycerol ingestion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerol ingestion (2.9 to 3.1 g/kg/d) with large volume of fluid (39.2 or 51.1 ml/kg/d)
Trial: 576817
Drug: Standard tablet
RxNorm normalized name: Stangard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard tablet formulation (5 mg)
Trial: 576817
Drug: Sustained-release capsule
RxNorm normalized name: Dilacor 240mg Sustained-Release Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release capsule formulation (20 mg)
Trial: 30522504
Drug: Thread-embedding acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thread-embedding acupuncture (TEA) with polydioxanone thread at 14 fixed acupoints, treatment once a week for 4 sessions
Trial: 30522504
Drug: Sham TEA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham TEA with a sham device (thread removed), treatment once a week for 4 sessions
Trial: 27400005
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg oral sildenafil citrate every 8 hours
Trial: 23431960
Drug: Cylindrical implants
RxNorm normalized name: Imperata cylindrica root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cylindrical implants (Group A)
Trial: 23431960
Drug: Conical/cylindrical implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conical/cylindrical implants (Group B)
Trial: 15590859
Drug: Both implant
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both implant types
Trial: 22005217
Drug: Palonosetron 0.25
RxNorm normalized name: palonosetron 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron 0.25 mg IV plus dexamethasone 8 mg IV on day 1
Trial: 22005217
Drug: Palonosetron 0.25
RxNorm normalized name: palonosetron 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron 0.25 mg IV plus dexamethasone 8 mg IV on day 1 followed by oral dexamethasone 8 mg on days 2 and 3
Trial: 21063118
Drug: Candesartan 8
RxNorm normalized name: candesartan 8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 8 mg once daily for 3-6 weeks before cardioversion and 16 mg once daily for 6 months after cardioversion
Trial: 15522993
Drug: Lipid +
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid + heparin emulsion
Trial: 11823085
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of ARBs and ACEIs
Trial: 2678858
Drug: Short-term antibiotic
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term antibiotic prophylaxis (cefotaxime for biliary or gastric, gentamicin/metronidazole for colorectal)
Trial: 2678858
Drug: Long-term antibiotic
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term antibiotic prophylaxis (cefotaxime for biliary or gastric, gentamicin/metronidazole for colorectal)
Trial: 1093498
Drug: Pentaeritritol administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentaeritritol administered for 4 weeks
Trial: 30772849
Drug: Anakinra in
RxNorm normalized name: anakinra Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra in addition to intravenous corticosteroid treatment
Trial: 30772849
Drug: Placebo in
RxNorm normalized name: placebo INTRAVEN VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo in addition to intravenous corticosteroid treatment
Trial: 23376004
Drug: LBTM (lansoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LBTM (lansoprazole 30 mg twice daily, bismuth potassium citrate 220 mg twice daily, tetracycline 500 mg 4 times daily, metronidazole 400 mg 4 times daily)
Trial: 23376004
Drug: LBTF (tetracycline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LBTF (tetracycline 500 mg 3 times daily, furazolidone 100 mg 3 times daily)
Trial: 23376004
Drug: LBAT (amoxicillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LBAT (amoxicillin 1000 mg 3 times daily, tetracycline 500 mg 4 times daily)
Trial: 23376004
Drug: LBAF (amoxicillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LBAF (amoxicillin 1000 mg 3 times daily, furazolidone 100 mg 3 times daily)
Trial: 19709060
Drug: Moderately rough
RxNorm normalized name: rough marshelder pollen extract
DrugBank: Iva annua pollen (DB10927)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderately rough (tioblasted) titanium implants
Trial: 19709060
Drug: Both implant
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both implant surfaces (tioblasted and turned)
Trial: 15154857
Drug: Chronic daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic daily headache
Trial: 15154857
Drug: Common analgesic
RxNorm normalized name: Common carp
DrugBank: Common carp (DB10614)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Common analgesic use
Trial: 11866419
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (20 minutes of preselected music)
Trial: 9516221
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Metformin and Troglitazone
Trial: 7750809
Drug: Levodopa methyl
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa methyl ester (LDME) 250 mg
Trial: 18165594
Drug: Epinephrine 4
RxNorm normalized name: EPINEPHrine 4 MG in 250 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine 4 microg/mL added to ropivacaine 1.8 mg/mL and fentanyl 3 microg/mL (group RFE)
Trial: 18165594
Drug: Ropivacaine 1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 1.8 mg/mL and fentanyl 3 microg/mL without epinephrine (group RF)
Trial: 9326900
Drug: Mandibular long-bar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular long-bar overdenture supported by 4 implants
Trial: 9326900
Drug: Two-implant hybrid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-implant hybrid overdenture
Trial: 8472518
Drug: ST-679 (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ST-679 (1200 mg per day)
Trial: 8472518
Drug: Tolmetin (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolmetin (1200 mg per day)
Trial: 24394884
Drug: Intravenous dexketoprofen
RxNorm normalized name: dexketoprofen
DrugBank: Dexketoprofen (DB09214)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dexketoprofen (50 mg)
Trial: 24455735
Drug: Intravenous paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous paracetamol (1000 mg)
Trial: 10513351
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (200 micrograms/dose q.i.d.)
Trial: 10513351
Drug: Budesonide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (200 micrograms/dose q.i.d.)
Trial: 7561195
Drug: Peru-15 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peru-15 vaccine (2 x 10^8 cfu)
Trial: 2324896
Drug: L-ascorbic acid
RxNorm normalized name: L-ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-ascorbic acid (AA) 284 mumol (50 mg) twice daily
Trial: 28267011
Drug: Oral sulfate
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sulfate solution
Trial: 19584830
Drug: Oral sulfate
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sulfate solution (split-dose)
Trial: 19584830
Drug: Oral sulfate
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sulfate solution (1-day preparation)
Trial: 19584830
Drug: PEG‐EA (1-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG‐EA (1-day preparation)
Trial: 19584830
Drug: Oral sulfate
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sulfate solution and PEG‐EA
Trial: 15136366
Drug: Rofecoxib, 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib, 25 mg/d plus aspirin 100 mg/d
Trial: 15136366
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus aspirin 100 mg/d
Trial: 11295882
Drug: Fluctuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluctuation of blood Phe values during treatment
Trial: 18476202
Drug: Electrocautery subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrocautery subcutaneous incision
Trial: 18476202
Drug: Scalpel subcutaneous
RxNorm normalized name: minoxidil
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Scalpel subcutaneous incision
Trial: 29154073
Drug: Aqueous extract
RxNorm normalized name: green tea aqueous extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous extract of edible dried fig fruit applied twice a day for two weeks
Trial: 29154073
Drug: Hydrocortisone 1.0%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone 1.0% applied twice a day for two weeks
Trial: 29154073
Drug: Base cream
RxNorm normalized name: U-Base Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Base cream (placebo) applied twice a day for two weeks
Trial: 23889837
Drug: Intensive Treatment
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive Treatment (IT): 100 hours of speech and language therapy (2 hours per day, 5 days per week for 10 weeks)
Trial: 23889837
Drug: Regular Treatment
RxNorm normalized name: Midol Regular
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular Treatment (RT): 100 hours of speech and language therapy (2 hours per week for 50 weeks)
Trial: 21510321
Drug: Lafutidine with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lafutidine with peppermint oil (10 mg lafutidine + 0.64 mL peppermint oil)
Trial: 21510321
Drug: Lafutidine alone
RxNorm normalized name: lafutidine
DrugBank: Lafutidine (DB12770)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lafutidine alone (10 mg)
Trial: 3415805
Drug: Ketanserin 40
RxNorm normalized name: ketanserin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin 40 mg bid for 6 weeks
Trial: 28259776
Drug: Rilpivirine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rilpivirine (25 mg), Emtricitabine (200 mg), Tenofovir alafenamide (25 mg)
Trial: 28259776
Drug: Efavirenz (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Efavirenz (600 mg), Emtricitabine (200 mg), Tenofovir disoproxil fumarate (300 mg)
Trial: 17416006
Drug: 250 ml/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 ml/d amino acids PN therapy
Trial: 17416006
Drug: 500 ml/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml/d amino acids PN therapy
Trial: 17416006
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no amino acids PN therapy)
Trial: 14687310
Drug: Micronutrient supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronutrient supplement providing the reference nutrient intake for all vitamins and trace elements
Trial: 7956393
Drug: OKY-046 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OKY-046 (200 mg twice a day for 3 days, 200 mg on the fourth day)
Trial: 3372915
Drug: Systemic steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic steroids pretreatment
Trial: 3372915
Drug: Topical steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical steroids pretreatment
Trial: 31262641
Drug: Nebulized heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized heparin (10,000 IU/4 h)
Trial: 28338362
Drug: T (50
RxNorm normalized name: MICRhoGAM 250 UNT (50 MCG) Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T (50 mg/kg BM)
Trial: 28338362
Drug: C (5
RxNorm normalized name: ferric (59Fe) citrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C (5 mg/kg BM)
Trial: 28338362
Drug: C +
RxNorm normalized name: Probiotic + Colostrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C + T (5 mg/kg BM + 50 mg/kg BM)
Trial: 28338362
Drug: P (5
RxNorm normalized name: salicylic acid 2 % Topical Gel (15 ML) / salicylic acid 1 % Medicated Liquid Soap (50 ML) Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P (5 mg/kg BM)
Trial: 21418096
Drug: 6-month Diabetes
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month Diabetes Medication Assistance Service
Trial: 21418096
Drug: 12-month Diabetes
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-month Diabetes Medication Assistance Service
Trial: 21418096
Drug: Diabetes Medication
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diabetes Medication Assistance Service (both 6 and 12 months)
Trial: 18204348
Drug: Methylphenidate 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate 0.3 to 0.4 mg/kg
Trial: 31253252
Drug: Spinal Manipulation
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal Manipulation Therapy (SMT)
Trial: 10218691
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% diluted 1:1 with glutathione bicarbonate Ringer solution
Trial: 1982059
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 mg/day)
Trial: 26676309
Drug: Sublingual desmopressin
RxNorm normalized name: desmopressin Sublingual Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual desmopressin (Minirin Melt) 60 μg
Trial: 26676309
Drug: Sublingual desmopressin
RxNorm normalized name: desmopressin Sublingual Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual desmopressin (Minirin Melt) 120 μg
Trial: 26676309
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 30 mg im ketorolac and 60 μg sublingual desmopressin
Trial: 26676309
Drug: Ketorolac tromethamine
RxNorm normalized name: Ketorolac Tromethamine
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac tromethamine (30 mg im)